Pirenzepine
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Pirenzepine".

This needs additional citations for verification. Please help improve this article by adding reliable references. Unsourced material may be challenged and removed. (June 2006)

Pirenzepine
Systematic (IUPAC) name
11-[(4-Methylpiperazin-1yl)acetyl]6,11-dihydro-5H-pyrido[2,3-b[1,4]benzodiazepin-6-on
Identifiers
CAS number	28797-61-7
ATC code	A02BX03
PubChem	4848
DrugBank	APRD00515
Chemical data
Formula	C19H21N5O2
Mol. mass	351.403 g/mol
Pharmacokinetic data
Bioavailability	?
Metabolism	?
Half life	?
Excretion	?
Therapeutic considerations
Pregnancy cat.	?
Legal status
Routes	?

Pirenzepine (marketed by Boehringer Ingelheim under the trade-name Gastrozepin) is used in the treatment of peptic ulcers, as it reduces gastric acid secretion and reduces muscle spasm. It is in a class of drugs known as muscarinic receptor antagonists - acetylcholine being the neurotransmitter of the parasympathetic nervous system which initiates the rest-and-digest state (as opposed to fight-or-flight), the result being an increase in gastric motility and digestion. It has no effects on the brain and spinal cord as it cannot diffuse through the blood-brain barrier.

Pirenzepine has been investigated for use in myopia control.^[1]

References

1. ^ Czepita D (2005). "Fundamentals of modern treatment of myopia". Ann Acad Med Stetin 51 (2): 5–9. PMID 16519089. 

This pharmacology-related article is a stub. You can help Wikipedia by expanding it.